Cascade Genetic Testing
Cascade Genetic Testing is a targeted genetic screening strategy that systematically identifies at-risk relatives within a family by first confirming a pathogenic germline variant in a proband and then extending testing to biologically related individuals in a stepwise, cost-effective manner to clarify their inherited cancer susceptibility status.
108
Publications
5.4K
Citations
775
Authors
334
Institutions
Publications per year
2017–2026
70
Variants
Cascade ScreeningFamily Cascade Testing
108
Zanfina Ademi, Gerald F. Watts, Jing Pang et al. · Journal of clinical lipidology · 2014 · 170 citations · Full text
B J Starr, S. G. Hadfield, Barbara A. Hutten et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 2008 · 163 citations
1–5 of 108
775
6
h-index
6
h-index
5
h-index
5
h-index
4
h-index
1–5 of 775
334

The University of Melbourne
Melbourne, Australia
8 h-index
29 publications
3.3K citations
Cancer Genetics (United States)
Rutherford, United States
7 h-index
21 publications
2.4K citations
Murdoch Children's Research Institute
Melbourne, Australia
7 h-index
30 publications
3.2K citations
Invitae (United States)
San Francisco, United States
7 h-index
29 publications
1.1K citations

The University of Western Australia
Perth, Australia
5 h-index
18 publications
1.7K citations
Royal Perth Hospital
Perth, Australia
4 h-index
13 publications
1.2K citations
The University of Texas MD Anderson Cancer Center
Houston, United States
4 h-index
10 publications
219 citations
Mayo Clinic
Rochester, United States
4 h-index
8 publications
209 citations
1–8 of 334
GIM · 7 publications · 631 citations
7
h-index
7 publications · 333 citations
7
h-index
6 publications · 330 citations
6
h-index
3 publications · 68 citations
3
h-index
JMG · 3 publications · 66 citations
3
h-index
1–5